Mandate

Vinge advises Axcel and Acurum Group in connection with the acquisitions of H3o Vatten & Fuktskador and Testab fog & sanering

Vinge has advised Axcel VII and Acurum Group in connection with the acquisitions of H3o Vatten & Fuktskador AB and Testab fog & sanering AB

H3o Vatten & Fuktskador AB and Testab fog & sanering AB are entrepreneur-led, local businesses with expertise in moisture control and moisture and remediation, respectively. Through the acquisition of H3o Vatten & Fuktskador AB, Acurum Group expands its offering in moisture control, with a particular focus on investigation and remediation of water and moisture damage. Testab fog & sanering AB complements the group with a broad offering in asbestos and PCB remediation, as well as other building technology remediation.

Acurum Group consists of companies offering services in air quality, moisture control and pipe maintenance, and has been operating since 2024. The group currently comprises 19 companies in Sweden and Norway, with approximately 600 employees and an annual turnover of approximately SEK 900 million. Each company operates under its own brand but grows through joint initiatives, collaboration and shared expertise within the group.

Vinge's team consisted of Christina Kokko, Elsie Nassar, Robin Sultani, Ida Appelgren and Emma Lundberg (M&A), Amelia Rihs (Employment), Calle Tengwall Pagels (Banking and Finance), Siri Blomberg (Commercial Agreements, IT and GDPR), Madelene Andersson and Stina Larsson (Real Property and Environment) and Julia Ulander Kull

Read the client's press releases here and here.

Related

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025

Vinge advises Advania in connection with the acquisition of atNorth HPC AB

Vinge has advised Advania, one of the leading IT companies in the Nordic region, in connection with the acquisition of atNorth HPC AB. The acquisition strengthens Advania's presence within high-performance computing (HPC).
October 03, 2025